62 related articles for article (PubMed ID: 3348911)
1. Characteristics of two malignant lymphomas in C57B1/6J mice. Cytogenetic changes and the distribution of i.v. transfused tumor cells with and without enzyme (pronase, neuraminidase) treatment.
Hagmar B; Ryd W; Stenman G
APMIS; 1988 Mar; 96(3):211-7. PubMed ID: 3348911
[TBL] [Abstract][Full Text] [Related]
2. Role of natural killer cells on engraftment of human lymphoid cells and on metastasis of human T-lymphoblastoid leukemia cells in C57BL/6J-scid mice and in C57BL/6J-scid bg mice.
Christianson SW; Greiner DL; Schweitzer IB; Gott B; Beamer GL; Schweitzer PA; Hesselton RM; Shultz LD
Cell Immunol; 1996 Aug; 171(2):186-99. PubMed ID: 8806787
[TBL] [Abstract][Full Text] [Related]
3. MCG101-AA, a new ascites tumour in C57 mice. 4. Influence of enzyme treatment on transplantability and some in vitro characteristics.
Hagmar B; Ryd W
Acta Pathol Microbiol Scand A; 1975 May; 83(3):328-38. PubMed ID: 1155101
[TBL] [Abstract][Full Text] [Related]
4. Nonrandom chromosomal changes in thy-1-positive and thy-1-negative lymphomas induced by 7,12-dimethylbenzanthracene in SJL mice.
Spira J; Babonits M; Wiener F; Ohno S; Wirschubski Z; Haran-Ghera N; Klein G
Cancer Res; 1980 Jul; 40(7):2609-16. PubMed ID: 6771002
[TBL] [Abstract][Full Text] [Related]
5. Analysis of changes in DNA copy number in radiation-induced thymic lymphomas of susceptible C57BL/6, resistant C3H and hybrid F1 Mice.
Takabatake T; Kakinuma S; Hirouchi T; Nakamura MM; Fujikawa K; Nishimura M; Oghiso Y; Shimada Y; Tanaka K
Radiat Res; 2008 Apr; 169(4):426-36. PubMed ID: 18363431
[TBL] [Abstract][Full Text] [Related]
6. [Establishment and characteristics of orthotopically transplanted model of human primary malignant spleen lymphoma in nude mice].
Liu Q; Zhao W; Tuo C; Wang Z; Wu B; Zhang N
Zhonghua Zhong Liu Za Zhi; 2002 May; 24(3):234-8. PubMed ID: 12515614
[TBL] [Abstract][Full Text] [Related]
7. Cell surface antigens expressed by subsets of pre-B cells and B cells.
McKearn JP; Baum C; Davie JM
J Immunol; 1984 Jan; 132(1):332-9. PubMed ID: 6606670
[TBL] [Abstract][Full Text] [Related]
8. Naturally occurring leukemia viruses in H-2 congenic C57BL mice. I. High lymphoma incidence following milk-borne transmission of virus.
Melief CJ; Vlug A; de Goede RE; de Bruyne C; Barendsen W; de Greeve P
J Natl Cancer Inst; 1980 May; 64(5):1179-89. PubMed ID: 6245301
[TBL] [Abstract][Full Text] [Related]
9. Carcinogenicity of 2',3'-dideoxycytidine in mice.
Rao GN; Collins BJ; Giles HD; Heath JE; Foley JF; May RD; Buckley LA
Cancer Res; 1996 Oct; 56(20):4666-72. PubMed ID: 8840982
[TBL] [Abstract][Full Text] [Related]
10. Array-CGH analyses of murine malignant lymphomas: genomic clues to understanding the effects of chronic exposure to low-dose-rate gamma rays on lymphomagenesis.
Takabatake T; Fujikawa K; Tanaka S; Hirouchi T; Nakamura M; Nakamura S; Braga-Tanaka I; Ichinohe K; Saitou M; Kakinuma S; Nishimura M; Shimada Y; Oghiso Y; Tanaka K
Radiat Res; 2006 Jul; 166(1 Pt 1):61-72. PubMed ID: 16808621
[TBL] [Abstract][Full Text] [Related]
11. Changes in anatomical distribution of tumour lesions induced by platelet-active drugs.
Willmott N; Malcolm A; McLeod T; Gracie A; Calman KC
Invasion Metastasis; 1983; 3(1):32-51. PubMed ID: 6677619
[TBL] [Abstract][Full Text] [Related]
12. Malignant cell arrest in thymus and spleen of mice bearing transplanted tumors.
Haran-Ghera N; Krauthgamer R; Peled A
J Immunol; 1981 Apr; 126(4):1241-4. PubMed ID: 6782158
[TBL] [Abstract][Full Text] [Related]
13. Prevention of Epstein-Barr virus-induced human B-cell lymphoma in severe combined immunodeficient mice treated with CD3xCD19 bispecific antibodies, CD28 monospecific antibodies, and autologous T cells.
Bohlen H; Manzke O; Titzer S; Lorenzen J; Kube D; Engert A; Abken H; Wolf J; Diehl V; Tesch H
Cancer Res; 1997 May; 57(9):1704-9. PubMed ID: 9135012
[TBL] [Abstract][Full Text] [Related]
14. Examinations concerning the development of lymphoma following transplantation i.p. of AKR mouse lymphoma cells into hybrid mice.
Selypes A; Berencsi G
Arch Geschwulstforsch; 1985; 55(2):111-6. PubMed ID: 3859254
[TBL] [Abstract][Full Text] [Related]
15. [Modulating effect of immunotherapy with modified tumor cells in transplantable lymphoma].
Bratus' GG; Darchuk GF; Komissarenko VG; Nastenko EP
Eksp Onkol; 1987; 9(2):36-40. PubMed ID: 3582237
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of a metastatic Eb-like tumor variant highly responsive to interleukin (IL)-2 and to combination cytokine therapy with IL-2/IL-1 beta and IL-1 beta/interferon-alpha/beta.
Gabriele L; Proietti E; Greco G; Venditti M; Gresser I; Schirrmacher V; Von Hoegen P; Testa U; Modesti A; Cianfriglia M
Invasion Metastasis; 1993; 13(3):147-62. PubMed ID: 8112975
[TBL] [Abstract][Full Text] [Related]
17. Accumulation of aberrant Y chromosomes in gamma-ray-induced thymic lymphomas lacking p53.
Chou D; Matsuki J; Saitou Y; Kosugi SI; Shinbo T; Gejyo F; Niwa O; Kominami R
Mol Carcinog; 1999 Nov; 26(3):157-62. PubMed ID: 10559790
[TBL] [Abstract][Full Text] [Related]
18. A new method for tolerance induction: busulfan administration followed by intravenous injection of neuraminidase-treated donor bone marrow.
Nagahama T; Sugiura K; Lee S; Morita H; Adachi Y; Kwon AH; Kamiyama Y; Ikehara S
Stem Cells; 2001; 19(5):425-35. PubMed ID: 11553851
[TBL] [Abstract][Full Text] [Related]
19. Characterization of preneoplastic thymocytes and of their neoplastic progression in irradiated C57BL/Ka mice.
Sen-Majumdar A; Guidos C; Kina T; Lieberman M; Weissman IL
J Immunol; 1994 Aug; 153(4):1581-92. PubMed ID: 8046233
[TBL] [Abstract][Full Text] [Related]
20. Splenic marginal zone B-cell and thymic T-cell lymphomas in p53-deficient mice.
Ward JM; Tadesse-Heath L; Perkins SN; Chattopadhyay SK; Hursting SD; Morse HC
Lab Invest; 1999 Jan; 79(1):3-14. PubMed ID: 9952106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
